Fundies. English
Segment disclosures
Company overviewSURMODICS INC
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
36 dimension combinations 615 retained observations 58 reported periods Partial retained history
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Operating Segments · Research Development And Other · Medical Device
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=srdx:ResearchDevelopmentAndOtherMember;us-gaap:StatementBusinessSegmentsAxis=srdx:MedicalDeviceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 2315000 | USD | 20240501 | Open filing evidence |
| 2023-10-01 – 2024-03-31 | 4731000 | USD | 20240501 | Open filing evidence |
| 2023-10-01 – 2023-12-31 | 2416000 | USD | 20240201 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 2364000 | USD | 20240501 | Open filing evidence |
| 2022-10-01 – 2023-03-31 | 4237000 | USD | 20240501 | Open filing evidence |
| 2022-10-01 – 2022-12-31 | 1873000 | USD | 20240201 | Open filing evidence |
Operating Segments · License · Medical Device
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:LicenseMember;us-gaap:StatementBusinessSegmentsAxis=srdx:MedicalDeviceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 25933000 | USD | 20230802 | Open filing evidence |
| 2022-10-01 – 2023-06-30 | 28645000 | USD | 20230802 | Open filing evidence |
| 2022-10-01 – 2023-03-31 | 2712000 | USD | 20230426 | Open filing evidence |
| 2022-10-01 – 2022-12-31 | 1356000 | USD | 20230206 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 5981000 | USD | 20221123 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 1024000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 1486000 | USD | 20230426 | Open filing evidence |
| 2021-10-01 – 2022-03-31 | 2699000 | USD | 20230426 | Open filing evidence |
| 2021-10-01 – 2021-12-31 | 1213000 | USD | 20230206 | Open filing evidence |
Operating Segments · License · Medical Device · Sur Veil DCB Abbott Agreement
Consolidation Items · Product Or Service · Statement Business Segments · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:LicenseMember;us-gaap:StatementBusinessSegmentsAxis=srdx:MedicalDeviceMember;us-gaap:SubsegmentsAxis=srdx:SurVeilDCBAbbottAgreementMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-10-01 – 2023-09-30 | 29586000 | USD | 20231122 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 16049000 | USD | 20231122 | Open filing evidence |
Operating Segments · Product · Medical Device
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=srdx:MedicalDeviceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 11100000 | USD | 20240501 | Open filing evidence |
| 2023-10-01 – 2024-03-31 | 23050000 | USD | 20240501 | Open filing evidence |
| 2023-10-01 – 2023-12-31 | 11950000 | USD | 20240201 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 7914000 | USD | 20240501 | Open filing evidence |
| 2022-10-01 – 2023-03-31 | 16294000 | USD | 20240501 | Open filing evidence |
| 2022-10-01 – 2022-12-31 | 8380000 | USD | 20240201 | Open filing evidence |
Operating Segments · In Vitro Diagnostics
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=srdx:InVitroDiagnosticsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-04-01 – 2025-06-30 | 7353000 | USD | 20250808 | Open filing evidence |
| 2024-10-01 – 2025-06-30 | 21370000 | USD | 20250808 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 7376000 | USD | 20250430 | Open filing evidence |
| 2024-10-01 – 2025-03-31 | 14017000 | USD | 20250430 | Open filing evidence |
| 2024-10-01 – 2024-12-31 | 6641000 | USD | 20250130 | Open filing evidence |
| 2023-10-01 – 2024-09-30 | 28570000 | USD | 20241120 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 6958000 | USD | 20250808 | Open filing evidence |
| 2023-10-01 – 2024-06-30 | 21097000 | USD | 20250808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 7132000 | USD | 20250430 | Open filing evidence |
| 2023-10-01 – 2024-03-31 | 14139000 | USD | 20250430 | Open filing evidence |
| 2023-10-01 – 2023-12-31 | 7007000 | USD | 20250130 | Open filing evidence |
| 2022-10-01 – 2023-09-30 | 26801000 | USD | 20241120 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 6469000 | USD | 20240731 | Open filing evidence |
| 2022-10-01 – 2023-06-30 | 19875000 | USD | 20240731 | Open filing evidence |
| 2022-10-01 – 2023-03-31 | 13406000 | USD | 20230426 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 27562000 | USD | 20241120 | Open filing evidence |
| 2021-10-01 – 2022-06-30 | 21074000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 7653000 | USD | 20230426 | Open filing evidence |
| 2021-10-01 – 2021-12-31 | 6095000 | USD | 20230206 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 26883000 | USD | 20231122 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 23463000 | USD | 20221123 | Open filing evidence |
| 2018-10-01 – 2019-09-30 | 21724000 | USD | 20211124 | Open filing evidence |
| 2017-10-01 – 2018-09-30 | 20823000 | USD | 20201202 | Open filing evidence |
| 2016-10-01 – 2017-09-30 | 19129000 | USD | 20191203 | Open filing evidence |
Operating Segments · In Vitro Diagnostics · Other Revenue
Consolidation Items · Statement Business Segments · Product Or Service
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=srdx:InVitroDiagnosticsMember;srt:ProductOrServiceAxis=srdx:OtherRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-10-01 – 2021-09-30 | 2182000 | USD | 20211124 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 754000 | USD | 20211124 | Open filing evidence |
| 2018-10-01 – 2019-09-30 | 334000 | USD | 20211124 | Open filing evidence |
| 2017-10-01 – 2018-09-30 | 34000 | USD | 20201202 | Open filing evidence |
| 2016-10-01 – 2017-09-30 | 74000 | USD | 20191203 | Open filing evidence |
Operating Segments · In Vitro Diagnostics · Research Development And Other
Consolidation Items · Statement Business Segments · Product Or Service
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=srdx:InVitroDiagnosticsMember;srt:ProductOrServiceAxis=srdx:ResearchDevelopmentAndOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-10-01 – 2023-09-30 | 313000 | USD | 20231122 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 101000 | USD | 20230802 | Open filing evidence |
| 2022-10-01 – 2023-06-30 | 217000 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 55000 | USD | 20230426 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 871000 | USD | 20231122 | Open filing evidence |
| 2021-10-01 – 2022-06-30 | 817000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 130000 | USD | 20230426 | Open filing evidence |
| 2021-10-01 – 2022-03-31 | 669000 | USD | 20230426 | Open filing evidence |
Operating Segments · In Vitro Diagnostics · Product
Consolidation Items · Statement Business Segments · Product Or Service
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=srdx:InVitroDiagnosticsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-04-01 – 2025-06-30 | 7221000 | USD | 20250808 | Open filing evidence |
| 2024-10-01 – 2025-06-30 | 20932000 | USD | 20250808 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 7279000 | USD | 20250430 | Open filing evidence |
| 2024-10-01 – 2025-03-31 | 13711000 | USD | 20250430 | Open filing evidence |
| 2024-10-01 – 2024-12-31 | 6432000 | USD | 20250130 | Open filing evidence |
| 2023-10-01 – 2024-09-30 | 27970000 | USD | 20241120 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 6836000 | USD | 20250808 | Open filing evidence |
| 2023-10-01 – 2024-06-30 | 20712000 | USD | 20250808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 6999000 | USD | 20250430 | Open filing evidence |
| 2023-10-01 – 2024-03-31 | 13876000 | USD | 20250430 | Open filing evidence |
| 2023-10-01 – 2023-12-31 | 6877000 | USD | 20250130 | Open filing evidence |
| 2022-10-01 – 2023-09-30 | 26488000 | USD | 20241120 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 6368000 | USD | 20240731 | Open filing evidence |
| 2022-10-01 – 2023-06-30 | 19658000 | USD | 20240731 | Open filing evidence |
| 2022-10-01 – 2022-12-31 | 5854000 | USD | 20230206 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 26691000 | USD | 20241120 | Open filing evidence |
| 2021-10-01 – 2022-06-30 | 20257000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 7523000 | USD | 20230426 | Open filing evidence |
| 2021-10-01 – 2021-12-31 | 5556000 | USD | 20230206 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 24701000 | USD | 20231122 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 22709000 | USD | 20221123 | Open filing evidence |
| 2018-10-01 – 2019-09-30 | 21390000 | USD | 20211124 | Open filing evidence |
| 2017-10-01 – 2018-09-30 | 20789000 | USD | 20201202 | Open filing evidence |
| 2016-10-01 – 2017-09-30 | 19055000 | USD | 20191203 | Open filing evidence |
Operating Segments · Medical Device
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=srdx:MedicalDeviceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-10-01 – 2025-06-30 | 66204000 | USD | 20250808 | Open filing evidence |
| 2024-10-01 – 2025-03-31 | 43990000 | USD | 20250430 | Open filing evidence |
| 2024-10-01 – 2024-12-31 | 23281000 | USD | 20250130 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 23383000 | USD | 20250808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 24826000 | USD | 20240501 | Open filing evidence |
| 2023-10-01 – 2024-03-31 | 48371000 | USD | 20250430 | Open filing evidence |
| 2023-10-01 – 2023-12-31 | 23545000 | USD | 20250130 | Open filing evidence |
| 2022-10-01 – 2023-09-30 | 105783000 | USD | 20241120 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 46014000 | USD | 20240731 | Open filing evidence |
| 2022-10-01 – 2023-06-30 | 84739000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 19707000 | USD | 20240501 | Open filing evidence |
| 2022-10-01 – 2023-03-31 | 38725000 | USD | 20240501 | Open filing evidence |
| 2022-10-01 – 2022-12-31 | 19018000 | USD | 20240201 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 72389000 | USD | 20241120 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 17528000 | USD | 20230802 | Open filing evidence |
| 2021-10-01 – 2022-06-30 | 52889000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 18453000 | USD | 20230426 | Open filing evidence |
| 2021-10-01 – 2022-03-31 | 35361000 | USD | 20230426 | Open filing evidence |
| 2021-10-01 – 2021-12-31 | 16908000 | USD | 20230206 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 78253000 | USD | 20231122 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 71401000 | USD | 20221123 | Open filing evidence |
| 2018-10-01 – 2019-09-30 | 78353000 | USD | 20211124 | Open filing evidence |
| 2017-10-01 – 2018-09-30 | 60513000 | USD | 20201202 | Open filing evidence |
| 2016-10-01 – 2017-09-30 | 53983000 | USD | 20191203 | Open filing evidence |
Operating Segments · Medical Device · Research Development And Other
Consolidation Items · Statement Business Segments · Product Or Service
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=srdx:MedicalDeviceMember;srt:ProductOrServiceAxis=srdx:ResearchDevelopmentAndOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-10-01 – 2023-09-30 | 9259000 | USD | 20231122 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 2562000 | USD | 20230802 | Open filing evidence |
| 2022-10-01 – 2023-06-30 | 6799000 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 2364000 | USD | 20230426 | Open filing evidence |
| 2022-10-01 – 2023-03-31 | 4237000 | USD | 20230426 | Open filing evidence |
| 2022-10-01 – 2022-12-31 | 1873000 | USD | 20230206 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 8211000 | USD | 20231122 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 1992000 | USD | 20230802 | Open filing evidence |
| 2021-10-01 – 2022-06-30 | 6181000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 2168000 | USD | 20230426 | Open filing evidence |
| 2021-10-01 – 2022-03-31 | 4189000 | USD | 20230426 | Open filing evidence |
| 2021-10-01 – 2021-12-31 | 2021000 | USD | 20230206 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 9420000 | USD | 20231122 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 9159000 | USD | 20221123 | Open filing evidence |
| 2018-10-01 – 2019-09-30 | 11277000 | USD | 20211124 | Open filing evidence |
| 2017-10-01 – 2018-09-30 | 7889000 | USD | 20201202 | Open filing evidence |
| 2016-10-01 – 2017-09-30 | 8528000 | USD | 20191203 | Open filing evidence |
Operating Segments · Medical Device · License
Consolidation Items · Statement Business Segments · Product Or Service
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=srdx:MedicalDeviceMember;srt:ProductOrServiceAxis=us-gaap:LicenseMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-04-01 – 2025-06-30 | 0 | USD | 20250808 | Open filing evidence |
| 2024-10-01 – 2025-06-30 | 1516000 | USD | 20250808 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 265000 | USD | 20250430 | Open filing evidence |
| 2024-10-01 – 2025-03-31 | 1516000 | USD | 20250430 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1134000 | USD | 20250808 | Open filing evidence |
| 2023-10-01 – 2024-06-30 | 3193000 | USD | 20250808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1088000 | USD | 20240501 | Open filing evidence |
| 2023-10-01 – 2024-03-31 | 2059000 | USD | 20240501 | Open filing evidence |
| 2023-10-01 – 2023-12-31 | 971000 | USD | 20250130 | Open filing evidence |
| 2022-10-01 – 2023-09-30 | 29586000 | USD | 20241120 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 25867000 | USD | 20240731 | Open filing evidence |
| 2022-10-01 – 2023-06-30 | 28494000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1331000 | USD | 20240501 | Open filing evidence |
| 2022-10-01 – 2023-03-31 | 2627000 | USD | 20240501 | Open filing evidence |
| 2022-10-01 – 2022-12-31 | 1296000 | USD | 20240201 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 5701000 | USD | 20241120 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 16275000 | USD | 20211124 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 12020000 | USD | 20211124 | Open filing evidence |
| 2018-10-01 – 2019-09-30 | 13678000 | USD | 20211124 | Open filing evidence |
| 2017-10-01 – 2018-09-30 | 4818000 | USD | 20201202 | Open filing evidence |
| 2016-10-01 – 2017-09-30 | 1456000 | USD | 20191203 | Open filing evidence |
Operating Segments · Medical Device · Product
Consolidation Items · Statement Business Segments · Product Or Service
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=srdx:MedicalDeviceMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-04-01 – 2025-06-30 | 9540000 | USD | 20250808 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 7714000 | USD | 20250430 | Open filing evidence |
| 2024-10-01 – 2024-12-31 | 10116000 | USD | 20250130 | Open filing evidence |
| 2023-10-01 – 2024-09-30 | 45620000 | USD | 20241120 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 10726000 | USD | 20240731 | Open filing evidence |
| 2023-10-01 – 2024-06-30 | 33776000 | USD | 20250808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 11100000 | USD | 20250430 | Open filing evidence |
| 2023-10-01 – 2023-12-31 | 11950000 | USD | 20250130 | Open filing evidence |
| 2022-10-01 – 2023-09-30 | 34126000 | USD | 20231122 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 9299000 | USD | 20240731 | Open filing evidence |
| 2022-10-01 – 2023-06-30 | 25593000 | USD | 20240731 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 7914000 | USD | 20230426 | Open filing evidence |
| 2022-10-01 – 2023-03-31 | 16294000 | USD | 20230426 | Open filing evidence |
| 2022-10-01 – 2022-12-31 | 8380000 | USD | 20230206 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 27930000 | USD | 20241120 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 6741000 | USD | 20230802 | Open filing evidence |
| 2021-10-01 – 2022-06-30 | 19970000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 6441000 | USD | 20230426 | Open filing evidence |
| 2021-10-01 – 2022-03-31 | 13229000 | USD | 20230426 | Open filing evidence |
| 2021-10-01 – 2021-12-31 | 6788000 | USD | 20230206 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 21777000 | USD | 20231122 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 21608000 | USD | 20221123 | Open filing evidence |
| 2018-10-01 – 2019-09-30 | 18617000 | USD | 20211124 | Open filing evidence |
| 2017-10-01 – 2018-09-30 | 17200000 | USD | 20201202 | Open filing evidence |
| 2016-10-01 – 2017-09-30 | 13735000 | USD | 20191203 | Open filing evidence |
Operating Segments · Medical Device · Royalty
Consolidation Items · Statement Business Segments · Product Or Service
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=srdx:MedicalDeviceMember;srt:ProductOrServiceAxis=us-gaap:RoyaltyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 8220000 | USD | 20230802 | Open filing evidence |
| 2022-10-01 – 2023-06-30 | 23702000 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 8073000 | USD | 20230426 | Open filing evidence |
| 2022-10-01 – 2023-03-31 | 15482000 | USD | 20230426 | Open filing evidence |
| 2022-10-01 – 2022-12-31 | 7409000 | USD | 20230206 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 30267000 | USD | 20221123 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 7771000 | USD | 20230802 | Open filing evidence |
| 2021-10-01 – 2022-06-30 | 23015000 | USD | 20230802 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 8358000 | USD | 20230426 | Open filing evidence |
| 2021-10-01 – 2022-03-31 | 15244000 | USD | 20230426 | Open filing evidence |
| 2021-10-01 – 2021-12-31 | 6886000 | USD | 20230206 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 30781000 | USD | 20221123 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 28614000 | USD | 20221123 | Open filing evidence |
| 2018-10-01 – 2019-09-30 | 34781000 | USD | 20211124 | Open filing evidence |
| 2017-10-01 – 2018-09-30 | 30606000 | USD | 20201202 | Open filing evidence |
| 2016-10-01 – 2017-09-30 | 30264000 | USD | 20191203 | Open filing evidence |
Operating Segments · Medical Device · Royalty · Performance Coatings
Consolidation Items · Statement Business Segments · Product Or Service · Subsegments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=srdx:MedicalDeviceMember;srt:ProductOrServiceAxis=us-gaap:RoyaltyMember;us-gaap:SubsegmentsAxis=srdx:PerformanceCoatingsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 10323000 | USD | 20240501 | Open filing evidence |
| 2023-10-01 – 2024-03-31 | 18531000 | USD | 20240501 | Open filing evidence |
| 2023-10-01 – 2023-12-31 | 8208000 | USD | 20240201 | Open filing evidence |
| 2022-10-01 – 2023-09-30 | 32812000 | USD | 20231122 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 8098000 | USD | 20240501 | Open filing evidence |
| 2022-10-01 – 2023-03-31 | 15567000 | USD | 20240501 | Open filing evidence |
| 2022-10-01 – 2022-12-31 | 7469000 | USD | 20240201 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 30547000 | USD | 20231122 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 31007000 | USD | 20231122 | Open filing evidence |
Research Development And Other · Operating Segments · In Vitro Diagnostics
Product Or Service · Consolidation Items · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=srdx:ResearchDevelopmentAndOtherMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=srdx:InVitroDiagnosticsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-04-01 – 2025-06-30 | 132000 | USD | 20250808 | Open filing evidence |
| 2024-10-01 – 2025-06-30 | 438000 | USD | 20250808 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 97000 | USD | 20250430 | Open filing evidence |
| 2024-10-01 – 2025-03-31 | 306000 | USD | 20250430 | Open filing evidence |
| 2024-10-01 – 2024-12-31 | 209000 | USD | 20250130 | Open filing evidence |
| 2023-10-01 – 2024-09-30 | 600000 | USD | 20241120 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 122000 | USD | 20250808 | Open filing evidence |
| 2023-10-01 – 2024-06-30 | 385000 | USD | 20250808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 133000 | USD | 20250430 | Open filing evidence |
| 2023-10-01 – 2024-03-31 | 263000 | USD | 20250430 | Open filing evidence |
| 2023-10-01 – 2023-12-31 | 130000 | USD | 20250130 | Open filing evidence |
| 2022-10-01 – 2023-09-30 | 313000 | USD | 20241120 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 101000 | USD | 20240731 | Open filing evidence |
| 2022-10-01 – 2023-06-30 | 217000 | USD | 20240731 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 871000 | USD | 20241120 | Open filing evidence |
Research Development And Other · Operating Segments · Medical Device
Product Or Service · Consolidation Items · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=srdx:ResearchDevelopmentAndOtherMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=srdx:MedicalDeviceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 3088000 | USD | 20250430 | Open filing evidence |
| 2024-10-01 – 2025-03-31 | 5619000 | USD | 20250430 | Open filing evidence |
| 2023-10-01 – 2024-09-30 | 9400000 | USD | 20241120 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 2199000 | USD | 20240731 | Open filing evidence |
| 2023-10-01 – 2024-06-30 | 6930000 | USD | 20250808 | Open filing evidence |
| 2023-10-01 – 2024-03-31 | 4731000 | USD | 20250430 | Open filing evidence |
| 2022-10-01 – 2023-09-30 | 9259000 | USD | 20241120 | Open filing evidence |
Research Development And Other · Medical Device · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=srdx:ResearchDevelopmentAndOtherMember;us-gaap:StatementBusinessSegmentsAxis=srdx:MedicalDeviceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-04-01 – 2025-06-30 | 3017000 | USD | 20250808 | Open filing evidence |
| 2024-10-01 – 2025-06-30 | 8636000 | USD | 20250808 | Open filing evidence |
| 2024-10-01 – 2024-12-31 | 2531000 | USD | 20250130 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 2199000 | USD | 20250808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 2315000 | USD | 20250430 | Open filing evidence |
| 2023-10-01 – 2023-12-31 | 2416000 | USD | 20250130 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 2562000 | USD | 20240731 | Open filing evidence |
| 2022-10-01 – 2023-06-30 | 6799000 | USD | 20240731 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 8211000 | USD | 20241120 | Open filing evidence |
License · Operating Segments · Medical Device
Product Or Service · Consolidation Items · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:LicenseMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=srdx:MedicalDeviceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 1356000 | USD | 20230426 | Open filing evidence |
| 2021-10-01 – 2022-06-30 | 3723000 | USD | 20230802 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 16275000 | USD | 20221123 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 12020000 | USD | 20221123 | Open filing evidence |
License · Operating Segments · Medical Device · Sur Veil DCB Abbott Agreement
Product Or Service · Consolidation Items · Statement Business Segments · Subsegments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:LicenseMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=srdx:MedicalDeviceMember;us-gaap:SubsegmentsAxis=srdx:SurVeilDCBAbbottAgreementMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-10-01 – 2022-09-30 | 5701000 | USD | 20231122 | Open filing evidence |
Operating Segments · In Vitro Diagnostics
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=srdx:InVitroDiagnosticsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2015-04-01 – 2015-06-30 | 4285000 | USD | 20150806 | Open filing evidence |
| 2014-10-01 – 2015-06-30 | 11708000 | USD | 20150806 | Open filing evidence |
| 2015-01-01 – 2015-03-31 | 3853000 | USD | 20150505 | Open filing evidence |
| 2014-10-01 – 2015-03-31 | 7422000 | USD | 20150505 | Open filing evidence |
| 2014-10-01 – 2014-12-31 | 3570000 | USD | 20150204 | Open filing evidence |
| 2013-10-01 – 2014-09-30 | 14371000 | USD | 20141205 | Open filing evidence |
| 2014-04-01 – 2014-06-30 | 3795000 | USD | 20150806 | Open filing evidence |
| 2013-10-01 – 2014-06-30 | 10251000 | USD | 20150806 | Open filing evidence |
| 2014-01-01 – 2014-03-31 | 3122000 | USD | 20150505 | Open filing evidence |
| 2013-10-01 – 2014-03-31 | 6456000 | USD | 20150505 | Open filing evidence |
| 2013-10-01 – 2013-12-31 | 3334000 | USD | 20150204 | Open filing evidence |
| 2012-10-01 – 2013-09-30 | 14979000 | USD | 20141205 | Open filing evidence |
| 2013-04-01 – 2013-06-30 | 3698000 | USD | 20140801 | Open filing evidence |
| 2012-10-01 – 2013-06-30 | 10978000 | USD | 20140801 | Open filing evidence |
| 2013-01-01 – 2013-03-31 | 3960000 | USD | 20140508 | Open filing evidence |
| 2012-10-01 – 2013-03-31 | 7280000 | USD | 20140508 | Open filing evidence |
| 2012-10-01 – 2012-12-31 | 3320000 | USD | 20140204 | Open filing evidence |
| 2011-10-01 – 2012-09-30 | 14045000 | USD | 20141205 | Open filing evidence |
| 2012-04-01 – 2012-06-30 | 3690000 | USD | 20130802 | Open filing evidence |
| 2011-10-01 – 2012-06-30 | 10196000 | USD | 20130802 | Open filing evidence |
| 2010-10-01 – 2011-09-30 | 13150000 | USD | 20131211 | Open filing evidence |
Operating Segments · Medical Device
Consolidation Items · Statement Business Segments
Source dimensions
us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=srdx:MedicalDeviceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2015-04-01 – 2015-06-30 | 11629000 | USD | 20150806 | Open filing evidence |
| 2014-10-01 – 2015-06-30 | 32827000 | USD | 20150806 | Open filing evidence |
| 2015-01-01 – 2015-03-31 | 10562000 | USD | 20150505 | Open filing evidence |
| 2014-10-01 – 2015-03-31 | 21198000 | USD | 20150505 | Open filing evidence |
| 2014-10-01 – 2014-12-31 | 10635000 | USD | 20150204 | Open filing evidence |
| 2013-10-01 – 2014-09-30 | 43068000 | USD | 20141205 | Open filing evidence |
| 2014-04-01 – 2014-06-30 | 10821000 | USD | 20150806 | Open filing evidence |
| 2013-10-01 – 2014-06-30 | 31852000 | USD | 20150806 | Open filing evidence |
| 2014-01-01 – 2014-03-31 | 10482000 | USD | 20150505 | Open filing evidence |
| 2013-10-01 – 2014-03-31 | 21031000 | USD | 20150505 | Open filing evidence |
| 2013-10-01 – 2013-12-31 | 10549000 | USD | 20150204 | Open filing evidence |
| 2012-10-01 – 2013-09-30 | 41153000 | USD | 20141205 | Open filing evidence |
| 2013-04-01 – 2013-06-30 | 10591000 | USD | 20140801 | Open filing evidence |
| 2012-10-01 – 2013-06-30 | 30857000 | USD | 20140801 | Open filing evidence |
| 2013-01-01 – 2013-03-31 | 9735000 | USD | 20140508 | Open filing evidence |
| 2012-10-01 – 2013-03-31 | 20266000 | USD | 20140508 | Open filing evidence |
| 2012-10-01 – 2012-12-31 | 10531000 | USD | 20140204 | Open filing evidence |
| 2011-10-01 – 2012-09-30 | 37883000 | USD | 20141205 | Open filing evidence |
| 2012-04-01 – 2012-06-30 | 10269000 | USD | 20130802 | Open filing evidence |
| 2011-10-01 – 2012-06-30 | 27889000 | USD | 20130802 | Open filing evidence |
| 2010-10-01 – 2011-09-30 | 39606000 | USD | 20131211 | Open filing evidence |
In Vitro Diagnostics
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=srdx:InVitroDiagnosticsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2013-01-01 – 2013-03-31 | 3960000 | USD | 20130510 | Open filing evidence |
| 2012-10-01 – 2013-03-31 | 7280000 | USD | 20130510 | Open filing evidence |
| 2012-10-01 – 2012-12-31 | 3320000 | USD | 20130208 | Open filing evidence |
| 2011-10-01 – 2012-09-30 | 14045000 | USD | 20121214 | Open filing evidence |
| 2012-04-01 – 2012-06-30 | 3690000 | USD | 20120809 | Open filing evidence |
| 2011-10-01 – 2012-06-30 | 10196000 | USD | 20120809 | Open filing evidence |
| 2012-01-01 – 2012-03-31 | 3457000 | USD | 20130510 | Open filing evidence |
| 2011-10-01 – 2012-03-31 | 6506000 | USD | 20130510 | Open filing evidence |
| 2011-10-01 – 2011-12-31 | 3049000 | USD | 20130208 | Open filing evidence |
| 2010-10-01 – 2011-09-30 | 13150000 | USD | 20121214 | Open filing evidence |
| 2011-04-01 – 2011-06-30 | 3440000 | USD | 20120809 | Open filing evidence |
| 2010-10-01 – 2011-06-30 | 9483000 | USD | 20120809 | Open filing evidence |
| 2009-10-01 – 2010-09-30 | 11194000 | USD | 20121214 | Open filing evidence |
In Vitro Diagnostics · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=srdx:InVitroDiagnosticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 7132000 | USD | 20240501 | Open filing evidence |
| 2023-10-01 – 2024-03-31 | 14139000 | USD | 20240501 | Open filing evidence |
| 2023-10-01 – 2023-12-31 | 7007000 | USD | 20240201 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 6469000 | USD | 20230802 | Open filing evidence |
| 2022-10-01 – 2023-06-30 | 19875000 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 7491000 | USD | 20240501 | Open filing evidence |
| 2022-10-01 – 2023-03-31 | 13406000 | USD | 20240501 | Open filing evidence |
| 2022-10-01 – 2022-12-31 | 5915000 | USD | 20240201 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 27562000 | USD | 20231122 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 7326000 | USD | 20230802 | Open filing evidence |
| 2021-10-01 – 2022-06-30 | 21074000 | USD | 20220727 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 7653000 | USD | 20220427 | Open filing evidence |
| 2021-10-01 – 2022-03-31 | 13748000 | USD | 20230426 | Open filing evidence |
| 2021-10-01 – 2021-12-31 | 6095000 | USD | 20220204 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 7118000 | USD | 20220727 | Open filing evidence |
| 2020-10-01 – 2021-06-30 | 20307000 | USD | 20220727 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 7088000 | USD | 20220427 | Open filing evidence |
| 2020-10-01 – 2021-03-31 | 13189000 | USD | 20220427 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 6101000 | USD | 20220204 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 6369000 | USD | 20210804 | Open filing evidence |
| 2019-10-01 – 2020-06-30 | 18099000 | USD | 20210804 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 6518000 | USD | 20210428 | Open filing evidence |
| 2019-10-01 – 2020-03-31 | 11730000 | USD | 20210428 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 5212000 | USD | 20210209 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 5399000 | USD | 20200805 | Open filing evidence |
| 2018-10-01 – 2019-06-30 | 15757000 | USD | 20200805 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 5375000 | USD | 20200430 | Open filing evidence |
| 2018-10-01 – 2019-03-31 | 10358000 | USD | 20200430 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 4983000 | USD | 20200207 | Open filing evidence |
| 2017-10-01 – 2018-09-30 | 20823000 | USD | 20181130 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 5526000 | USD | 20190801 | Open filing evidence |
| 2017-10-01 – 2018-06-30 | 14771000 | USD | 20190801 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 5006000 | USD | 20190503 | Open filing evidence |
| 2017-10-01 – 2018-03-31 | 9245000 | USD | 20190503 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 4239000 | USD | 20190201 | Open filing evidence |
| 2016-10-01 – 2017-09-30 | 19129000 | USD | 20181130 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 5012000 | USD | 20180806 | Open filing evidence |
| 2016-10-01 – 2017-06-30 | 13794000 | USD | 20180806 | Open filing evidence |
| 2015-10-01 – 2016-09-30 | 18164000 | USD | 20181130 | Open filing evidence |
In Vitro Diagnostics · Operating Segments · Other Revenue
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=srdx:InVitroDiagnosticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=srdx:OtherRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2020-06-30 | 145000 | USD | 20200805 | Open filing evidence |
| 2019-10-01 – 2020-06-30 | 608000 | USD | 20200805 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 203000 | USD | 20200430 | Open filing evidence |
| 2019-10-01 – 2020-03-31 | 463000 | USD | 20200430 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 260000 | USD | 20200207 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 29000 | USD | 20200805 | Open filing evidence |
| 2018-10-01 – 2019-06-30 | 85000 | USD | 20200805 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 46000 | USD | 20200430 | Open filing evidence |
| 2018-10-01 – 2019-03-31 | 56000 | USD | 20200430 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 10000 | USD | 20200207 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 9000 | USD | 20190801 | Open filing evidence |
| 2017-10-01 – 2018-06-30 | 17000 | USD | 20190801 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 7000 | USD | 20190503 | Open filing evidence |
| 2017-10-01 – 2018-03-31 | 8000 | USD | 20190503 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 2000 | USD | 20190201 | Open filing evidence |
In Vitro Diagnostics · Operating Segments · Research Development And Other
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=srdx:InVitroDiagnosticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=srdx:ResearchDevelopmentAndOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 133000 | USD | 20240501 | Open filing evidence |
| 2023-10-01 – 2024-03-31 | 263000 | USD | 20240501 | Open filing evidence |
| 2023-10-01 – 2023-12-31 | 130000 | USD | 20240201 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 55000 | USD | 20240501 | Open filing evidence |
| 2022-10-01 – 2023-03-31 | 116000 | USD | 20240501 | Open filing evidence |
| 2022-10-01 – 2022-12-31 | 61000 | USD | 20240201 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 871000 | USD | 20221123 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 148000 | USD | 20230802 | Open filing evidence |
| 2021-10-01 – 2022-06-30 | 817000 | USD | 20220727 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 130000 | USD | 20220427 | Open filing evidence |
| 2021-10-01 – 2022-03-31 | 669000 | USD | 20220427 | Open filing evidence |
| 2021-10-01 – 2021-12-31 | 539000 | USD | 20230206 | Open filing evidence |
| 2020-10-01 – 2021-09-30 | 2182000 | USD | 20231122 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 527000 | USD | 20220727 | Open filing evidence |
| 2020-10-01 – 2021-06-30 | 1802000 | USD | 20220727 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 715000 | USD | 20220427 | Open filing evidence |
| 2020-10-01 – 2021-03-31 | 1275000 | USD | 20220427 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 560000 | USD | 20220204 | Open filing evidence |
| 2019-10-01 – 2020-09-30 | 754000 | USD | 20221123 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 145000 | USD | 20210804 | Open filing evidence |
| 2019-10-01 – 2020-06-30 | 608000 | USD | 20210804 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 203000 | USD | 20210428 | Open filing evidence |
| 2019-10-01 – 2020-03-31 | 463000 | USD | 20210428 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 260000 | USD | 20210209 | Open filing evidence |
In Vitro Diagnostics · Operating Segments · Product
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=srdx:InVitroDiagnosticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 6999000 | USD | 20240501 | Open filing evidence |
| 2023-10-01 – 2024-03-31 | 13876000 | USD | 20240501 | Open filing evidence |
| 2023-10-01 – 2023-12-31 | 6877000 | USD | 20240201 | Open filing evidence |
| 2022-10-01 – 2023-09-30 | 26488000 | USD | 20231122 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 6368000 | USD | 20230802 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 7436000 | USD | 20240501 | Open filing evidence |
| 2022-10-01 – 2023-03-31 | 13290000 | USD | 20240501 | Open filing evidence |
| 2022-10-01 – 2022-12-31 | 5854000 | USD | 20240201 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 7178000 | USD | 20230802 | Open filing evidence |
| 2021-10-01 – 2022-06-30 | 20257000 | USD | 20220727 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 7523000 | USD | 20220427 | Open filing evidence |
| 2021-10-01 – 2022-03-31 | 13079000 | USD | 20230426 | Open filing evidence |
| 2021-10-01 – 2021-12-31 | 5556000 | USD | 20220204 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 6591000 | USD | 20220727 | Open filing evidence |
| 2020-10-01 – 2021-06-30 | 18505000 | USD | 20220727 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 6373000 | USD | 20220427 | Open filing evidence |
| 2020-10-01 – 2021-03-31 | 11914000 | USD | 20220427 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 5541000 | USD | 20220204 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 6224000 | USD | 20210804 | Open filing evidence |
| 2019-10-01 – 2020-06-30 | 17491000 | USD | 20210804 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 6315000 | USD | 20210428 | Open filing evidence |
| 2019-10-01 – 2020-03-31 | 11267000 | USD | 20210428 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 4952000 | USD | 20210209 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 5370000 | USD | 20200805 | Open filing evidence |
| 2018-10-01 – 2019-06-30 | 15672000 | USD | 20200805 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 5329000 | USD | 20200430 | Open filing evidence |
| 2018-10-01 – 2019-03-31 | 10302000 | USD | 20200430 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 4973000 | USD | 20200207 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 5517000 | USD | 20190801 | Open filing evidence |
| 2017-10-01 – 2018-06-30 | 14754000 | USD | 20190801 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 4999000 | USD | 20190503 | Open filing evidence |
| 2017-10-01 – 2018-03-31 | 9237000 | USD | 20190503 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 4237000 | USD | 20190201 | Open filing evidence |
In Vitro Diagnostics · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=srdx:InVitroDiagnosticsMember;us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-03-31 | 5006000 | USD | 20180504 | Open filing evidence |
| 2017-10-01 – 2018-03-31 | 9245000 | USD | 20180504 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 4239000 | USD | 20180208 | Open filing evidence |
| 2016-10-01 – 2017-09-30 | 19129000 | USD | 20171201 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 5012000 | USD | 20170803 | Open filing evidence |
| 2016-10-01 – 2017-06-30 | 13794000 | USD | 20170803 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 4777000 | USD | 20180504 | Open filing evidence |
| 2016-10-01 – 2017-03-31 | 8782000 | USD | 20180504 | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 4004000 | USD | 20180208 | Open filing evidence |
| 2015-10-01 – 2016-09-30 | 18164000 | USD | 20171201 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 4318000 | USD | 20170803 | Open filing evidence |
| 2015-10-01 – 2016-06-30 | 13712000 | USD | 20170803 | Open filing evidence |
| 2016-01-01 – 2016-03-31 | 5100000 | USD | 20170428 | Open filing evidence |
| 2015-10-01 – 2016-03-31 | 9394000 | USD | 20170428 | Open filing evidence |
| 2015-10-01 – 2015-12-31 | 4294000 | USD | 20170203 | Open filing evidence |
| 2014-10-01 – 2015-09-30 | 15954000 | USD | 20171201 | Open filing evidence |
| 2015-04-01 – 2015-06-30 | 4285000 | USD | 20160729 | Open filing evidence |
| 2014-10-01 – 2015-06-30 | 11708000 | USD | 20160729 | Open filing evidence |
| 2015-01-01 – 2015-03-31 | 3853000 | USD | 20160510 | Open filing evidence |
| 2014-10-01 – 2015-03-31 | 7422000 | USD | 20160510 | Open filing evidence |
| 2014-10-01 – 2014-12-31 | 3570000 | USD | 20160205 | Open filing evidence |
| 2013-10-01 – 2014-09-30 | 14371000 | USD | 20161202 | Open filing evidence |
| 2012-10-01 – 2013-09-30 | 14979000 | USD | 20151204 | Open filing evidence |
Medical Device
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=srdx:MedicalDeviceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2013-01-01 – 2013-03-31 | 9735000 | USD | 20130510 | Open filing evidence |
| 2012-10-01 – 2013-03-31 | 20266000 | USD | 20130510 | Open filing evidence |
| 2012-10-01 – 2012-12-31 | 10531000 | USD | 20130208 | Open filing evidence |
| 2011-10-01 – 2012-09-30 | 37883000 | USD | 20121214 | Open filing evidence |
| 2012-04-01 – 2012-06-30 | 10269000 | USD | 20120809 | Open filing evidence |
| 2011-10-01 – 2012-06-30 | 27889000 | USD | 20120809 | Open filing evidence |
| 2012-01-01 – 2012-03-31 | 8753000 | USD | 20130510 | Open filing evidence |
| 2011-10-01 – 2012-03-31 | 17620000 | USD | 20130510 | Open filing evidence |
| 2011-10-01 – 2011-12-31 | 8867000 | USD | 20130208 | Open filing evidence |
| 2010-10-01 – 2011-09-30 | 39606000 | USD | 20121214 | Open filing evidence |
| 2011-04-01 – 2011-06-30 | 9559000 | USD | 20120809 | Open filing evidence |
| 2010-10-01 – 2011-06-30 | 29372000 | USD | 20120809 | Open filing evidence |
| 2009-10-01 – 2010-09-30 | 43294000 | USD | 20121214 | Open filing evidence |
Medical Device · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=srdx:MedicalDeviceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-04-01 – 2025-06-30 | 22214000 | USD | 20250808 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 20709000 | USD | 20250430 | Open filing evidence |
| 2023-10-01 – 2024-09-30 | 97508000 | USD | 20241120 | Open filing evidence |
| 2023-10-01 – 2024-06-30 | 71754000 | USD | 20250808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 24826000 | USD | 20250430 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 17528000 | USD | 20220727 | Open filing evidence |
| 2021-10-01 – 2022-06-30 | 52889000 | USD | 20220727 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 18453000 | USD | 20220427 | Open filing evidence |
| 2021-10-01 – 2022-03-31 | 35361000 | USD | 20220427 | Open filing evidence |
| 2021-10-01 – 2021-12-31 | 16908000 | USD | 20220204 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 16755000 | USD | 20220727 | Open filing evidence |
| 2020-10-01 – 2021-06-30 | 60858000 | USD | 20220727 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 27907000 | USD | 20220427 | Open filing evidence |
| 2020-10-01 – 2021-03-31 | 44103000 | USD | 20220427 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 16196000 | USD | 20220204 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 20514000 | USD | 20210804 | Open filing evidence |
| 2019-10-01 – 2020-06-30 | 54222000 | USD | 20210804 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 16304000 | USD | 20210428 | Open filing evidence |
| 2019-10-01 – 2020-03-31 | 33708000 | USD | 20210428 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 17404000 | USD | 20210209 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 18945000 | USD | 20200805 | Open filing evidence |
| 2018-10-01 – 2019-06-30 | 53504000 | USD | 20200805 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 17301000 | USD | 20200430 | Open filing evidence |
| 2018-10-01 – 2019-03-31 | 34559000 | USD | 20200430 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 17258000 | USD | 20200207 | Open filing evidence |
| 2017-10-01 – 2018-09-30 | 60513000 | USD | 20181130 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 16701000 | USD | 20190801 | Open filing evidence |
| 2017-10-01 – 2018-06-30 | 43527000 | USD | 20190801 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 14052000 | USD | 20190503 | Open filing evidence |
| 2017-10-01 – 2018-03-31 | 26826000 | USD | 20190503 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 12774000 | USD | 20190201 | Open filing evidence |
| 2016-10-01 – 2017-09-30 | 53983000 | USD | 20181130 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 12778000 | USD | 20180806 | Open filing evidence |
| 2016-10-01 – 2017-06-30 | 39260000 | USD | 20180806 | Open filing evidence |
| 2015-10-01 – 2016-09-30 | 53202000 | USD | 20181130 | Open filing evidence |
Medical Device · Operating Segments · Research Development And Other
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=srdx:MedicalDeviceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=srdx:ResearchDevelopmentAndOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 1992000 | USD | 20220727 | Open filing evidence |
| 2021-10-01 – 2022-06-30 | 6181000 | USD | 20220727 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 2168000 | USD | 20220427 | Open filing evidence |
| 2021-10-01 – 2022-03-31 | 4189000 | USD | 20220427 | Open filing evidence |
| 2021-10-01 – 2021-12-31 | 2021000 | USD | 20220204 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 2466000 | USD | 20220727 | Open filing evidence |
| 2020-10-01 – 2021-06-30 | 7212000 | USD | 20220727 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 2445000 | USD | 20220427 | Open filing evidence |
| 2020-10-01 – 2021-03-31 | 4746000 | USD | 20220427 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 2301000 | USD | 20220204 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 2353000 | USD | 20210804 | Open filing evidence |
| 2019-10-01 – 2020-06-30 | 7215000 | USD | 20210804 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 2628000 | USD | 20210428 | Open filing evidence |
| 2019-10-01 – 2020-03-31 | 4862000 | USD | 20210428 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 2234000 | USD | 20210209 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 2821000 | USD | 20200805 | Open filing evidence |
| 2018-10-01 – 2019-06-30 | 8016000 | USD | 20200805 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 2811000 | USD | 20200430 | Open filing evidence |
| 2018-10-01 – 2019-03-31 | 5195000 | USD | 20200430 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 2384000 | USD | 20200207 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 2146000 | USD | 20190801 | Open filing evidence |
| 2017-10-01 – 2018-06-30 | 5931000 | USD | 20190801 | Open filing evidence |
Medical Device · Operating Segments · License
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=srdx:MedicalDeviceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:LicenseMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-10-01 – 2024-12-31 | 1251000 | USD | 20250130 | Open filing evidence |
| 2023-10-01 – 2024-09-30 | 5080000 | USD | 20241120 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1134000 | USD | 20240731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1088000 | USD | 20250430 | Open filing evidence |
| 2023-10-01 – 2024-03-31 | 2059000 | USD | 20250430 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 1024000 | USD | 20220727 | Open filing evidence |
| 2021-10-01 – 2022-06-30 | 3723000 | USD | 20220727 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 1486000 | USD | 20220427 | Open filing evidence |
| 2021-10-01 – 2022-03-31 | 2699000 | USD | 20220427 | Open filing evidence |
| 2021-10-01 – 2021-12-31 | 1213000 | USD | 20220204 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 1044000 | USD | 20220727 | Open filing evidence |
| 2020-10-01 – 2021-06-30 | 15047000 | USD | 20220727 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 12578000 | USD | 20220427 | Open filing evidence |
| 2020-10-01 – 2021-03-31 | 14003000 | USD | 20220427 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 1425000 | USD | 20220204 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 7646000 | USD | 20210804 | Open filing evidence |
| 2019-10-01 – 2020-06-30 | 10402000 | USD | 20210804 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 1507000 | USD | 20210428 | Open filing evidence |
| 2019-10-01 – 2020-03-31 | 2756000 | USD | 20210428 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 1249000 | USD | 20210209 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 2019000 | USD | 20200805 | Open filing evidence |
| 2018-10-01 – 2019-06-30 | 6049000 | USD | 20200805 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 1619000 | USD | 20200430 | Open filing evidence |
| 2018-10-01 – 2019-03-31 | 4030000 | USD | 20200430 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 2411000 | USD | 20200207 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 1867000 | USD | 20190801 | Open filing evidence |
| 2017-10-01 – 2018-06-30 | 2438000 | USD | 20190801 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 537000 | USD | 20190503 | Open filing evidence |
| 2017-10-01 – 2018-03-31 | 571000 | USD | 20190503 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 34000 | USD | 20190201 | Open filing evidence |
Medical Device · Operating Segments · Product
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=srdx:MedicalDeviceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-10-01 – 2025-06-30 | 27370000 | USD | 20250808 | Open filing evidence |
| 2024-10-01 – 2025-03-31 | 17830000 | USD | 20250430 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 10726000 | USD | 20250808 | Open filing evidence |
| 2023-10-01 – 2024-03-31 | 23050000 | USD | 20250430 | Open filing evidence |
| 2022-10-01 – 2023-09-30 | 34126000 | USD | 20241120 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 6741000 | USD | 20220727 | Open filing evidence |
| 2021-10-01 – 2022-06-30 | 19970000 | USD | 20220727 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 6441000 | USD | 20220427 | Open filing evidence |
| 2021-10-01 – 2022-03-31 | 13229000 | USD | 20220427 | Open filing evidence |
| 2021-10-01 – 2021-12-31 | 6788000 | USD | 20220204 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 5493000 | USD | 20220727 | Open filing evidence |
| 2020-10-01 – 2021-06-30 | 15464000 | USD | 20220727 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 5410000 | USD | 20220427 | Open filing evidence |
| 2020-10-01 – 2021-03-31 | 9971000 | USD | 20220427 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 4561000 | USD | 20220204 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 5763000 | USD | 20210804 | Open filing evidence |
| 2019-10-01 – 2020-06-30 | 16240000 | USD | 20210804 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 5455000 | USD | 20210428 | Open filing evidence |
| 2019-10-01 – 2020-03-31 | 10477000 | USD | 20210428 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 5023000 | USD | 20210209 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 4500000 | USD | 20200805 | Open filing evidence |
| 2018-10-01 – 2019-06-30 | 13836000 | USD | 20200805 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 4558000 | USD | 20200430 | Open filing evidence |
| 2018-10-01 – 2019-03-31 | 9336000 | USD | 20200430 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 4778000 | USD | 20200207 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 4958000 | USD | 20190801 | Open filing evidence |
| 2017-10-01 – 2018-06-30 | 12495000 | USD | 20190801 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 3687000 | USD | 20190503 | Open filing evidence |
| 2017-10-01 – 2018-03-31 | 7537000 | USD | 20190503 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 3850000 | USD | 20190201 | Open filing evidence |
Medical Device · Operating Segments · Royalty
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=srdx:MedicalDeviceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:RoyaltyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-04-01 – 2022-06-30 | 7771000 | USD | 20220727 | Open filing evidence |
| 2021-10-01 – 2022-06-30 | 23015000 | USD | 20220727 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 8358000 | USD | 20220427 | Open filing evidence |
| 2021-10-01 – 2022-03-31 | 15244000 | USD | 20220427 | Open filing evidence |
| 2021-10-01 – 2021-12-31 | 6886000 | USD | 20220204 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 7752000 | USD | 20220727 | Open filing evidence |
| 2020-10-01 – 2021-06-30 | 23135000 | USD | 20220727 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 7474000 | USD | 20220427 | Open filing evidence |
| 2020-10-01 – 2021-03-31 | 15383000 | USD | 20220427 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 7909000 | USD | 20220204 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 4752000 | USD | 20210804 | Open filing evidence |
| 2019-10-01 – 2020-06-30 | 20365000 | USD | 20210804 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 6714000 | USD | 20210428 | Open filing evidence |
| 2019-10-01 – 2020-03-31 | 15613000 | USD | 20210428 | Open filing evidence |
| 2019-10-01 – 2019-12-31 | 8898000 | USD | 20210209 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 9605000 | USD | 20200805 | Open filing evidence |
| 2018-10-01 – 2019-06-30 | 25603000 | USD | 20200805 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 8313000 | USD | 20200430 | Open filing evidence |
| 2018-10-01 – 2019-03-31 | 15998000 | USD | 20200430 | Open filing evidence |
| 2018-10-01 – 2018-12-31 | 7685000 | USD | 20200207 | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 7730000 | USD | 20190801 | Open filing evidence |
| 2017-10-01 – 2018-06-30 | 22663000 | USD | 20190801 | Open filing evidence |
| 2018-01-01 – 2018-03-31 | 7891000 | USD | 20190503 | Open filing evidence |
| 2017-10-01 – 2018-03-31 | 14933000 | USD | 20190503 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 7042000 | USD | 20190201 | Open filing evidence |
Medical Device · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=srdx:MedicalDeviceMember;us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2018-01-01 – 2018-03-31 | 14052000 | USD | 20180504 | Open filing evidence |
| 2017-10-01 – 2018-03-31 | 26826000 | USD | 20180504 | Open filing evidence |
| 2017-10-01 – 2017-12-31 | 12774000 | USD | 20180208 | Open filing evidence |
| 2016-10-01 – 2017-09-30 | 53983000 | USD | 20171201 | Open filing evidence |
| 2017-04-01 – 2017-06-30 | 12778000 | USD | 20170803 | Open filing evidence |
| 2016-10-01 – 2017-06-30 | 39260000 | USD | 20170803 | Open filing evidence |
| 2017-01-01 – 2017-03-31 | 12726000 | USD | 20180504 | Open filing evidence |
| 2016-10-01 – 2017-03-31 | 26482000 | USD | 20180504 | Open filing evidence |
| 2016-10-01 – 2016-12-31 | 13757000 | USD | 20180208 | Open filing evidence |
| 2015-10-01 – 2016-09-30 | 53202000 | USD | 20171201 | Open filing evidence |
| 2016-04-01 – 2016-06-30 | 15654000 | USD | 20170803 | Open filing evidence |
| 2015-10-01 – 2016-06-30 | 39500000 | USD | 20170803 | Open filing evidence |
| 2016-01-01 – 2016-03-31 | 11599000 | USD | 20170428 | Open filing evidence |
| 2015-10-01 – 2016-03-31 | 23846000 | USD | 20170428 | Open filing evidence |
| 2015-10-01 – 2015-12-31 | 12247000 | USD | 20170203 | Open filing evidence |
| 2014-10-01 – 2015-09-30 | 45944000 | USD | 20171201 | Open filing evidence |
| 2015-04-01 – 2015-06-30 | 11629000 | USD | 20160729 | Open filing evidence |
| 2014-10-01 – 2015-06-30 | 32827000 | USD | 20160729 | Open filing evidence |
| 2015-01-01 – 2015-03-31 | 10562000 | USD | 20160510 | Open filing evidence |
| 2014-10-01 – 2015-03-31 | 21198000 | USD | 20160510 | Open filing evidence |
| 2014-10-01 – 2014-12-31 | 10635000 | USD | 20160205 | Open filing evidence |
| 2013-10-01 – 2014-09-30 | 43068000 | USD | 20161202 | Open filing evidence |
| 2012-10-01 – 2013-09-30 | 41153000 | USD | 20151204 | Open filing evidence |
Performance Coatings · Operating Segments · Medical Device · Royalty
Subsegments · Consolidation Items · Statement Business Segments · Product Or Service
Source dimensions
us-gaap:SubsegmentsAxis=srdx:PerformanceCoatingsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=srdx:MedicalDeviceMember;srt:ProductOrServiceAxis=us-gaap:RoyaltyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-10-01 – 2025-06-30 | 28682000 | USD | 20250808 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 9642000 | USD | 20250430 | Open filing evidence |
| 2024-10-01 – 2025-03-31 | 19025000 | USD | 20250430 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 9324000 | USD | 20240731 | Open filing evidence |
| 2023-10-01 – 2024-06-30 | 27855000 | USD | 20250808 | Open filing evidence |
| 2023-10-01 – 2024-03-31 | 18531000 | USD | 20250430 | Open filing evidence |
| 2022-10-01 – 2023-09-30 | 32812000 | USD | 20241120 | Open filing evidence |
| 2021-10-01 – 2022-09-30 | 30547000 | USD | 20241120 | Open filing evidence |
Performance Coatings · Medical Device · Operating Segments · Royalty
Subsegments · Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:SubsegmentsAxis=srdx:PerformanceCoatingsMember;us-gaap:StatementBusinessSegmentsAxis=srdx:MedicalDeviceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=us-gaap:RoyaltyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-04-01 – 2025-06-30 | 9657000 | USD | 20250808 | Open filing evidence |
| 2024-10-01 – 2024-12-31 | 9383000 | USD | 20250130 | Open filing evidence |
| 2023-10-01 – 2024-09-30 | 37408000 | USD | 20241120 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 9324000 | USD | 20250808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 10323000 | USD | 20250430 | Open filing evidence |
| 2023-10-01 – 2023-12-31 | 8208000 | USD | 20250130 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 8286000 | USD | 20240731 | Open filing evidence |
| 2022-10-01 – 2023-06-30 | 23853000 | USD | 20240731 | Open filing evidence |